Lysosomal enzymes in experimental diabetic cardiomyopathy

Area of Science:

• Cardiology
• Biochemistry
• Genetics

Background:

• Diabetic cardiomyopathy is a significant complication of diabetes.
• Genetic models of diabetes, like the db+/db+ mouse, are crucial for studying disease mechanisms.
• Lysosomal enzymes play vital roles in cellular waste disposal and homeostasis.

Purpose of the Study:

• To investigate the role of cardiac lysosomal enzymes in the development of cardiomyopathy in genetically diabetic mice (db+/db+).
• To quantify specific lysosomal enzyme activities in the hearts of diabetic mice compared to controls.

Main Methods:

• Age-matched pairs of db+/db+ mice and their littermate controls were used (5-26 weeks).
• Hearts were excised and homogenized.
• Activities of 11 key lysosomal enzymes were measured, including N-Acetyl-beta-glucosaminidase, beta-glucuronidase, and acid phosphatase.

Main Results:

• A progressive decrease in cardiac lysosomal enzyme activities was observed in db+/db+ mice from 5 to 21 weeks of age.
• Significant depression of enzyme activity occurred between 9-21 weeks.
• Beta-glucuronidase, aryl sulphatase, and beta-glucosidase activities were reduced by approximately 40-50%.

Conclusions:

• Decreased lysosomal enzyme activity in the diabetic mouse heart correlates with cardiomyopathy.
• The observed enzyme reduction can explain the accumulation of residual bodies and interstitial material in the myocardium.
• This finding highlights the importance of lysosomal function in diabetic cardiac pathology.